At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
09688 ZAI LAB
Trading 08-19 13:08:10
20.220
+0.930
+4.82%
High20.620
Low19.820
Vol7.36M
Open20.060
D1 Closing19.290
Amplitude4.15%
Mkt Cap23.01B
Tradable Cap23.01B
Total Shares1.14B
T/O149.09M
T/O Rate0.65%
Tradable Shares1.14B
P/B--
ROE--
EPS0.00
52wk High--
52wk Low--
P/E--
Dividend--
Div.Yield--
ROA--
Loading ...
Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.
Movement Alert｜ZAI LAB Rises 6.27% in Regular Trading, Efgartigimod Phase 3 Clinical Success Plus Broker Initiates Overweight Rating
Zai Lab Ltd is a holding company primarily engaged in biopharmaceutical business. The Company is focused on discovering, developing, and commercializing products that address medical conditions with significant unmet needs in the areas of oncology, immunology, neuroscience, and infectious disease. The Company has a series of patented drug candidates from the discovery stage to the late clinical project, including ZEJULA, OPTUNE, QINLOCK, NUZYRA and VYVGART, and others. The Company conducts its businesses within domestic and overseas markets.